COMMUNIQUÉS West-GlobeNewswire

Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update

08/08/2024 - 22:05

- Initial readout from first-line RAS-mut. mCRC randomized CRDF-004 trial expected in 2H 2024 - - Published preclinical data underscores the ability of onvansertib to overcome resistance to PARP inhibitors in high-grade [...]

scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

08/08/2024 - 22:05

Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and [...]

Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance

08/08/2024 - 22:05

─ Reports $3.6M in Q2 2024 Revenue; 50% Gross Margin ─ Raises FY 2024 Revenue Guidance to $13-16M GUILFORD, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology [...]

Seer Reports Second Quarter 2024 Financial Results

08/08/2024 - 22:05

Launched STAC in Europe and additional customer papers published in leading journals REDWOOD CITY, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a [...]

ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

08/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune [...]

Iridex Reports Second Quarter 2024 Financial Results

08/08/2024 - 22:05

MOUNTAIN VIEW, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]

Greg Horn Honored with NBJ Lifetime Achievement Award For Transformative Impact on Health and Wellness

07/08/2024 - 22:28

RANCHO PALOS VERDES, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Nutrition Business Journal (NBJ) honored Greg Horn with the prestigious NBJ Lifetime Achievement Award at the NBJ Summit on July 31. Presented in front [...]

Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results

07/08/2024 - 22:17

Announced acquisition of CT-95, a mesothelin x CD3 bispecific antibody Claudio Dansky Ullmann, M.D. named Chief Medical Officer Cash and cash equivalents of $101.5 million as of June 30, 2024 PHILADELPHIA, Aug. 07, 2024 [...]

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

07/08/2024 - 22:15

DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, [...]

Health Catalyst Reports Second Quarter 2024 Results

07/08/2024 - 22:13

SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported [...]

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

07/08/2024 - 22:11

Delivered Robust Revenue Performance, Fueled by Exceptional Commercial Execution and Early Success of the U.S. AGAMREE ® Product Launch Reported Record Q2 2024 Total Revenues of $122.7 Million, Representing a 23.2% YoY [...]

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2024 Financial Guidance Ranges

07/08/2024 - 22:10

Total Company Revenue increased 13.9% to $459.7 million in the second quarter of 2024 from $403.7 million in the second quarter of 2023; Revenue from the Digital Health reportable segment (inclusive of intersegment [...]

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

07/08/2024 - 22:06

Conference call begins at 4:30 p.m. Eastern time today MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June [...]

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024

07/08/2024 - 22:05

Conference Call Scheduled for Wednesday, August 14, 2024 at 9:00 AM ET PORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]

Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress

07/08/2024 - 22:05

Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing [...]

Jushi Holdings Inc. Reports Second Quarter 2024 Financial Results

07/08/2024 - 22:05

Margin Growth with Gross Profit and Gross Margin Reaching $32.6 Million and 50.4% , Respectively Net Loss of $1.9 Million , Compared to $14.0 Million in Q2 2023 Grew Adjusted EBITDA and Adjusted EBITDA Margin to $14.5 [...]

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

07/08/2024 - 22:05

Reported dose-dependent antitumor clinical activity in patients with relapsed/refractory triple-negative breast cancer from the Phase 1 trial of LYL797, a ROR1-targeted Chimeric Antigen Receptor (CAR) T‑cell product [...]

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results

07/08/2024 - 22:05

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid [...]

LifeMD Reports Second Quarter 2024 Results

07/08/2024 - 22:05

Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight management [...]